Clinical trial
Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received…
NCT00003412 · Beth Israel Deaconess Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00003412 |
|---|---|
| Title | Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received High-Dose Chemotherapy and Peripheral Stem Cell Transplantation |
| Official title | Phase I Study of Post Transplant rhIL-12 High Dose Cyclophosphamide, Thiotepa, and Carboplatin in the Treatment of Metastatic Breast Carcinoma |
| Lead sponsor | Beth Israel Deaconess Medical Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Biological |
| Interventions | recombinant interleukin-12 |
| Enrollment | 35 |
| Start date | Jun 1, 1998 |
| First posted | Mar 31, 2004 |
| Last update posted | Sep 17, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: